GlassScriptPhysician profile
Charles S Thompson
NPI 1396724571
$6,472.39
in general payments reported to CMS, 2019-2025
26 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $378 · 2021: $1,090 · 2022: $1,211 · 2023: $253 · 2024: $1,782 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,920 · Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,920.00 |
| Food and Beverage | $1,524.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,920.00 | 2024-2025 | Venacure 1470 Pro |
| W. L. Gore & Associates, INC. | $1,179.89 | 2019-2025 | Gore Acuseal Cardiovascular Patch Vascular, Gore Acuseal Vascular Graft, Gore Tag Thoracic Endoprosthesis |
| Endologix LLC | $676.44 | 2020-2022 | |
| Silk Road Medical, INC. | $526.23 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Bolton Medical INC | $473.99 | 2021-2025 | Treo Abdominal Stent-Graft System |
| Bard Peripheral Vascular, INC. | $451.15 | 2019-2024 | Fluency Endovascular Stent Graft |
| Cvrx, INC. | $268.80 | 2024-2025 | Barostim Neo System |
| Cardiovascular Systems INC. | $201.83 | 2019-2022 | |
| Medtronic, INC. | $179.37 | 2021-2023 | Venaseal |
| Boston Scientific Corporation | $87.07 | 2019-2024 | Watchman Access System |
| Medtronic Vascular, INC. | $84.47 | 2019-2020 | |
| Artivion, INC. | $51.97 | 2024 | Photofix Decellularized Bovine Pericardium, Vascular, Bioglue Surgical Adhesive |
| Asd Specialty Healthcare, LLC | $49.79 | 2019 | |
| Cashflow Solutions, LLC | $49.18 | 2022-2024 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Smith+Nephew, INC. | $34.24 | 2022-2025 | Renasys Touch |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $34.22 | 2019 | |
| Polymedics Innovations INC. | $28.81 | 2025 | |
| Penumbra, INC. | $26.89 | 2022-2023 | Indigo System, Ruby Coil |
| Innovation Technologies INC | $23.41 | 2022 | |
| Abbott Laboratories | $22.07 | 2022 | |
| Pfizer INC. | $18.79 | 2024 | |
| Guard Medical INC. | $18.05 | 2024 | Npseal Large |
| Becton, Dickinson and Company | $17.24 | 2025 | Covera |
| Molnlycke Health Care US, LLC | $16.46 | 2024 | Mepilex Border Post-Op Ag, Exufiber Ag+, Mextra Superabsorbant |
| Organogenesis INC. | $16.18 | 2024 | |
| Kerecis Limited | $15.85 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.